首页|年龄因素对咪达唑仑口服溶液缓解小儿术前焦虑疗效的影响

年龄因素对咪达唑仑口服溶液缓解小儿术前焦虑疗效的影响

扫码查看
目的 评价年龄因素对咪达唑仑口服溶液缓解小儿术前焦虑疗效的影响。方法 选取拟行全身麻醉的择期手术患儿,年龄1~6岁,性别不限,美国麻醉医师协会分级Ⅰ~Ⅱ级,按年龄分为幼儿组(1≤年龄≤3岁)和儿童组(3<年龄≤6岁)。2组首例患儿均给予咪达唑仑口服溶液0。5 mg·kg-1,根据患儿改良Ramsay镇静评分、与父母分离的焦虑评分及入室后面罩诱导接受评分的情况,采用偏性掷币设计的上下序贯法决定下一例患儿口服咪达唑仑口服溶液的剂量。记录和比较2组患儿给药时的行为评分和镇静期间不良反应。根据患儿用药剂量,采用保序回归分析计算咪达唑仑口服溶液用于缓解小儿术前焦虑的95%有效剂量(ED95)及相应95%置信区间(95%CI)。结果 幼儿组的 ED95 为 0。83mg·kg-1(95%CI:0。69~0。88 mg·kg-1),儿童组的 ED95 为 0。89mg·kg-1(95%CI:0。69~0。97 mg·kg-1),2组比较无显著差异(P>0。05)。综合分析计算出咪达唑仑口服溶液缓解年龄1~6岁小儿术前焦虑的ED95为 0。89 mg·kg-1(95%CI:0。79~0。97 mg·kg-1)。2组患儿给药时行为评分存在显著差异(P<0。05),患儿家长满意度比较无显著差异(P>0。05)。2组患儿在诱导期和麻醉苏醒期间均未发生低氧血症、呼吸抑制、恶心呕吐等不良反应。结论 咪达唑仑口服溶液缓解小儿术前焦虑的疗效不受年龄的影响。咪达唑仑口服溶液用于缓解1~6岁小儿术前焦虑的ED95为0。89 mg·kg-1。
Impact of age on efficacy of midazolam oral solution in alleviating preoperative anxiety in pediatric patients
AIM To evaluate the influence of age on the effectiveness of midazolam oral solution in managing preoperative anxiety in pediatric patients.METHODS Pediatric patients,aged 1 to 6 years,scheduled for elective surgery under general anesthesia,regardless of gender,American Society of Anesthesiologists Ⅰ-Ⅱ classification,were divided into two age groups:infants(1 ≤ age≤3 years)and children(3<age ≤ 6 years).The initial dose of oral midazolam solution administered was 0.5 mg·kg-1.Subsequent dosages were determined using a bias coin design dose-up-and-down sequential method,based on the patient's modified Ramsay sedation score,parental separation anxiety score,and facemask induction score after admission.The behavior scores and adverse reactions during sedation between the two groups were recorded and compared.The 95%effective dose(ED95)and corresponding 95%confidence interval(95%CI)of midazolam oral solution for preoperative anxiety relief in children was calculated through isostatic regression analysis.RESULTS The ED95 for infants and children was 0.83 mg·kg-1(95%CI:0.69 to 0.88 mg·kg-1)and 0.89 mg·kg-1(95%CI:0.69 to 0.97 mg·kg-1),respectively.No statistically significant difference in ED95was observed between the two groups(P>0.05).A comprehensive analysis of both age groups yielded an overall ED95 of 0.89 mg·kg-1(95%CI:0.79 to 0.97 mg·kg-1)for midazolam oral solution in alleviating preoperative anxiety in children aged 1 to 6 years.There was a statistically significant difference in the behavior scores between the two groups(P<0.05),but no difference in parental satisfaction(P>0.05).Adverse events including hypoxemia,respiratory depression,nausea and vomiting were not observed in the two groups during the induction period and the anesthesia recovery period.CONCLUSION The efficacy of midazolam oral solution in alleviating preoperative anxiety in children is not affected by age.The dose of ED95 for relieving preoperative anxiety in children aged 1 to 6 years is 0.89 mg·kg-1.

midazolamage factorschildanxietypreoperative perioddrug dosage calculations

刘广博、熊虹飞、程菲、张芸芸、卫子雯、梁雯雯、李思远

展开 >

西安国际医学中心医院麻醉与舒适化医疗部,陕西西安 710100

中国人民大学,北京 100872

咪达唑仑 年龄因素 儿童 焦虑 手术前期间 药物剂量计算

2024

中国新药与临床杂志
中国药学会 上海市食品药品监督管理局科技情报研究所

中国新药与临床杂志

CSTPCD北大核心
影响因子:0.967
ISSN:1007-7669
年,卷(期):2024.43(6)
  • 20